|
Match
|
Document |
Document Title |
|
|
US20090291877 |
TREATMENTS USING CITRULLINE
The invention provides a method and formulation for the treatment or maintenance of conditions that would be benefited from increasing or maintaining Arginine levels in the blood, and having...
|
|
|
US20090258030 |
Materials and Methods for Improving Livestock Productivity
The subject invention provides methods for improving livestock health. In specific embodiments, the invention provides methods for accelerating and/or augmenting livestock growth; improving...
|
|
|
US20090232917 |
COMPOSITION FOR RELIEVING SUBJECTIVE SYMPTOMS OF FATIGUE
There has been a demand in the marketplace for medicines, functional foods and so on which can relieve subjective symptoms of fatigue in persons having these subjective symptoms, and enabling the...
|
|
|
US20090203784 |
TREATMENT REGIMEN FOR N-MYC, C-MYC, AND L-MYC AMPLIFIED AND OVEREXPRESSED TUMORS
The present invention relates to methods and compositions for treating diseases. More specifically, the present invention relates to the administration of multiple drugs as part of a treatment of...
|
|
|
US20090191152 |
INTRALYMPHATIC CHEMOTHERAPY DRUG CARRIERS
A chemotherapeutic composition can be configured for subcutaneous administration for preferential intralymphatic accumulation while also providing a therapeutic systemic concentration that is not...
|
|
|
US20090156537 |
COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES
The present invention provides compositions and methods useful for detecting or treating asthma or other allergic or inflammatory diseases. In one aspect, the methods of the present invention...
|
|
|
US20090155379 |
Nutritional composition for facilitating muscle pumps
A composition for providing a method for creating and prolonging muscle pumps, providing a transducer effect for nitric oxide, increasing nutrient delivery and promoting increased vascular response...
|
|
|
US20090137654 |
METHODS OF MODULATING BINDING OF SON OF SEVENLESS TO PHOSPHATIDIC ACID AND IDENTIFYING COMPOUNDS THAT MODULATE SUCH BINDING
The present invention relates to methods of modulating binding of Son of sevenless to phosphatidic acid and identifying compounds that modulate such binding. In particular, the present invention...
|
|
|
US20090104114 |
Nanotherapeutic Colloidal Metal Compositions and Methods
The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and...
|
|
|
US20090098169 |
MODIFIED CLAY MINERAL
Modified clay minerals obtained by treating a clay mineral with a particular acylarginine derivative are useful for stabilizing emulsion compositions, inter alia, W/O emulsion composition, while...
|
|
|
US20090074885 |
Reversible Hydrophobic Modification of Drugs for Improved Delivery to Cells
Described are drug formulations that increase regional delivery of the drugs to cells. Methods for reversibly increasing the hydrophobicity of a drug through hydrolytically labile attachment of a...
|
|
|
US20090068094 |
INHIBITORS OF ENDO-EXONUCLEASE ACTIVITY FOR TREATING CANCER
The present invention relates to the treatment of cancer with compounds that inhibit the activity of endo-exonuclease. Endo-exonuclease has been shown to be necessary for the repair of damaged DNA....
|
|
|
US20090054308 |
Methods and Compositions for Treating Pulmonary Hypertension and Related Diseases and Disorders
Methods of treating pulmonary hypertension are disclosed. Particular methods comprise the administration of a tryptophan hydroxylase inhibitor and at least one other active pharmaceutical...
|
|
|
US20090030005 |
Combinations for the treatment of cancer
This invention is in the field of pharmaceutical agents and specifically relates to combinations, compositions, uses and methods for treating cancer.
|
|
|
US20090028937 |
TABLET COMPRISING ORNITHINE HYDROCHLORIDE
The present invention has an object to provide a tablet capable of comprising ornithine hydrochloride in a higher content; and a process for producing the same, and provides the tablet comprising...
|
|
|
US20080319076 |
COMPOSITIONS COMPRISING CREATINE SALTS AND METHODS OF USE THEREOF
The invention relates to compositions (e.g., nutritional supplements) comprising, consisting essentially of, or consisting of a creatine bicarbonate, and to methods of making and using said...
|
|
|
US20080317870 |
Compositions and Mehtods for Treating and Preventing Cancer Using Analogs of Vitamin D
Disclosed are compositions and methods used to treat and/or prevent cancer and metabolic diseases, such as psoriasis. In one aspect, the present invention pertains to the use of cross-linking...
|
|
|
US20080267862 |
METHOD OF TREATING CANCER
Present invention provides a method for treating cancer which comprises co-administration of an angiogenic agent to enhance the vascular supply within tumors, particularly tumors capable of...
|
|
|
US20080260708 |
METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY
Methods, systems and formulations for normalizing and improving human body chemistry and the body's natural ability to heal itself. In one embodiment a system including effective amounts of a...
|
|
|
US20080255234 |
RUMEN PROTECTED LYSINE
Use of lysine imines and compositions containing them as a source of rumen protected lysine for ruminant animals.
|
|
|
US20080241165 |
Cross-beta structure comprising amyloid-binding proteins and methods for detection of the cross-beta structure, for modulating cross-beta structures fiber formation and modulating cross-beta structure-mediated toxicity
The invention relates to the field of biochemistry, molecular biology, structural biology and medicine. More in particular, the invention relates to cross-β structures and the biological role of...
|
|
|
US20080234379 |
THERAPEUTIC METHODS EMPLOYING NITRIC OXIDE PRECURSORS
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic...
|
|
|
US20080233208 |
USE OF ERIANIN IN PREPARING PHARMACEUTICAL FOR TREATING TUMORS
This invention relates to a use of the compound of formula (I), Erianin, in preparing pharmaceutical for treating tumors
|
|
|
US20080213403 |
Method for treating pulmonary disease states in mammals by altering indigenous in vivo levels of nitric oxide
The present invention provides a method for treating a pulmonary disease state in mammals by protecting indigenous in vivo levels of nitric oxide in mammalian cells comprising contacting the...
|
|
|
US20080206290 |
COSMETIC COMBINATION PRODUCT FOR IMPROVING APPEARANCE
A cosmetic combination product, wherein the product comprises at least two components selected from (a) one or more dietary supplements, (b) one or more cosmetic preparations for topical...
|
|
|
US20080206222 |
Preventive/Therapeutic Composition For Free Radical Disease
A preventive/therapeutic composition for free radical diseases, characterized by containing as an active ingredient at least one kind of a fullerene, a fullerene derivative, and a composite...
|
|
|
US20080194665 |
Compositions Based on Amino Acids for Improving the Myocardial Ventricular Function in Patients Suffering from Diabetes
Compositions based on amino acids are described, for improving the myocardial ventricular function in patients suffering from diabetes, particularly but not exclusively II type diabetes. The...
|
|
|
US20080194467 |
CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS
Improved methods for treating cancer which employ combinations comprising cadherin antagonists with certain anticancer agents or treatments are provided. The methods of the invention involve the...
|
|
|
US20080182811 |
METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
Amino acids other than glutamic acid are used as a metabotropic glutamate receptor activator. More preferably, aspartic acid, valine and cysteine are used as a group I metabotropic glutamate...
|
|
|
US20080153889 |
Compositions and Methods for the Treatment of Renal and Cardiovascular Disease
Derivative compounds of 11-nonyloxy-undec- 8 (Z)-eonic acid that mimic epoxide metabolites are provided. Also provided are compositions comprising a therapeutically effective amount of the...
|
|
|
US20080145458 |
FORMULATIONS USEFUL IN THE TREATMENT OF MALE AND FEMALE IMPOTENCE
Pharmaceutical compositions containing: extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia in the weight ratio of 1.5-3.5:1-2:0.1-0.4 respectively; and optionally arginine or a...
|
|
|
US20080119554 |
Compositions Comprising Ornithine And Phenylacetate Or Phenylbutyrate For Treating Hepatic Encephalopathy
The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating liver...
|
|
|
US20080119421 |
Process for treating a biological organism
A process for treating a biological organism, comprising the steps in which a cell cycle arresting drug is administered to the organism to produce synchronized cells, the microtubules within the...
|
|
|
US20080108684 |
THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-ALFA PRODUCTION INHIBITOR
Disclosed is an agent for use in the treatment or prevention of inflammatory bowel disease. Also disclosed is an agent for inhibiting the production of TNF-α. A therapeutic or prophylactic agent...
|
|
|
US20080090772 |
Oligosaccharide Aldonic Acids and Their Topical Use
Compositions comprising oligosaccharide aldonic acids are useful for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including...
|
|
|
US20080076796 |
Methods and Compositions for the Treatment of Alcoholism and Alcohol Dependence
Use is disclosed of (a) an AlDH-inhibitory amount of a Trp metabolite, or an analogue or derivative thereof or (b) a bioprecursor thereof, or (c) a potentiator of (a) and/or (b), in the preparation...
|
|
|
US20080064731 |
REMEDY FOR CHRONIC DISEASE
A remedy and/or a preventive for a chronic disease which contains an EDG-2 antagonist. Because of binding to a subtype EDG-2 of LPA receptor, an EDG-2 antagonist is useful in treating and/or...
|
|
|
US20080057136 |
Disinfecting Composition and Methods of Making and Using Same
The invention relates to antimicrobial compositions that can be used for disinfecting and can be applied in various aspects of the national economy, medicine, and laboratories of all types. The...
|
|
|
US20080033040 |
Methods And Compositions For Screening Involving Endothelial Cells Under Shearing Conditions
The present invention concerns screening methods and compositions relating to endothelial cell function. More specifically, it provides screening methods to identify or characterize pathways and...
|
|
|
US20080015227 |
Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
The present invention relates to compounds of formula (I).
wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , m, n, p and q are defined herein Pharmaceutical compositions and methods for treating...
|
|
|
US20080014184 |
METHODS OF TREATING FIBROMYALGIA CAUSED BY SMALL INTESTINAL BACTERIAL OVERGROWTH
Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple...
|
|
|
US20080009498 |
Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use
The invention provides novel compositions containing at least one phosphodiesterase inhibitor, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels...
|
|
|
US20080004321 |
Potentiators of Glutamate Receptors
The present invention provides a compound of formula (I): pharmaceutical compositions thereof, and methods of using the same, processes for preparing the same, and intermediates thereof.
|